What characterizes a hybrid decentralized clinical trial model?
Answer
Essential procedures might require an in-person visit, while routine follow-ups are managed remotely.
A hybrid model blends remote elements with necessary in-person visits. Essential procedures like initial informed consent or specialized imaging may still require travel, but assessments and routine follow-ups are handled remotely.
Related Questions
What is the primary shift defining decentralized clinical trials (DCTs)?What characterizes a hybrid decentralized clinical trial model?Which technologies are paramount for remote data capture in DCTs?Besides shipping investigational product, what else do Direct-to-Patient (DtP) services coordinate?What critical enabling factor ensures a DCT is more than just disconnected digital tasks?How does the workload for site staff primarily shift in a decentralized structure?What aptitude do successful site personnel need beyond traditional clinical research management in a DCT?How do decentralized trials impact participant recruitment and retention benefits?According to CTTI guidance, when should planning for decentralized elements begin?What action prevents massive data reconciliation efforts late in decentralized trials?